Drupal.behaviors.print = function(context) {window.print();window.close();}>
Genomic Health to Launch NGS-based Somatic Cancer Mutation Detection Platform for Pharma Research
January 25, 2012
Genomic Health to Launch NGS-based Somatic Cancer Mutation Detection Platform for Pharma Research
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Foundation Medicine, MSKCC to Develop Sequencing-based Blood Cancer Test from DNA, RNA
May 8, 2013 / Clinical Sequencing News
Foundation Medicine Raises $33.5M to Support Commercialization of Cancer Dx Panel
October 19, 2011 / Clinical Sequencing News
Foundation Medicine Shows Sequencing-based Cancer Test Can ID Clinically Actionable Mutations
June 8, 2011 / Clinical Sequencing News
At AACR, Early Providers of NGS-based Cancer Panels Debate 'Actionable' Mutations, Regulatory Issues
April 10, 2013 / Clinical Sequencing News
Foundation Medicine to Develop Dx for Agios Cancer Therapeutics
April 4, 2013 / GenomeWeb Daily News